KEYSTONE PHARMA CONSULTING LIMITED

Company number 09403717 ·

Active

Net assets, total assets & total liabilities 2017 – 2026

  • Total assets
  • Net assets
  • Total liabilities
-£50k £0 £50k £100k £150k £200k 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Total assets 2019: £42,918 Total assets 2020: £60,563 Total assets 2021: £128,744 Total assets 2022: £173,564 Total assets 2023: £137,716 Total assets 2024: £134,137 Total assets 2025: £170,834 Total assets 2026: £190,977 Total assets Net assets 2017: -£4,871 Net assets 2018: -£25,806 Net assets 2019: £19,503 Net assets 2020: £25,611 Net assets 2021: £82,991 Net assets 2022: £126,287 Net assets 2023: £104,750 Net assets 2024: £92,527 Net assets 2025: £123,285 Net assets 2026: £143,472 Net assets Total liabilities 2017: -£24,631 Total liabilities 2018: -£29,608 Total liabilities 2019: -£21,790 Total liabilities 2020: -£34,172 Total liabilities 2021: -£44,616 Total liabilities 2022: -£46,366 Total liabilities 2023: -£32,202 Total liabilities 2024: -£40,222 Total liabilities 2025: -£46,165 Total liabilities 2026: -£45,826 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2025 – 2026

0 0 1 1 2 2 3 3 4 2025 2026 2025: 4 2026: 4

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 11 years

Latest accounts (2026-03-31): Audit exempt.

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2026-03-31 £190,977 -£45,826 £143,472 4
2025-03-31 £170,834 -£46,165 £123,285 4
2024-03-31 £134,137 -£40,222 £92,527
2023-03-31 £137,716 -£32,202 £104,750
2022-03-31 £173,564 -£46,366 £126,287
2021-03-31 £128,744 -£44,616 £82,991
2020-03-31 £60,563 -£34,172 £25,611
2019-03-31 £42,918 -£21,790 £19,503
2018-03-31 -£29,608 -£25,806
2017-03-31 -£24,631 -£4,871
2016-03-31 -£42,710 -£471

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.